| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.0032 | 1 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |